Detalles de la búsqueda
1.
ANGPTL3 Deficiency and Risk of Hepatic Steatosis.
Circulation;
148(19): 1479-1489, 2023 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37712257
2.
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Nutr Metab Cardiovasc Dis;
2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693036
3.
Sustained increase in physical fitness independently predicts improvements in cardiometabolic risk profile in type 2 diabetes.
Diabetes Metab Res Rev;
39(6): e3671, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37312666
4.
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials.
Diabetes Obes Metab;
25(9): 2535-2544, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37254688
5.
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
Diabetes Obes Metab;
25(7): 1890-1899, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906837
6.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Diabetes Obes Metab;
25(1): 46-55, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111434
7.
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study.
Nutr Metab Cardiovasc Dis;
33(11): 2294-2305, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37679243
8.
Outpatient healthcare costs associated with overweight and obesity in Italy.
BMC Health Serv Res;
23(1): 619, 2023 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37308927
9.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J;
243: 232-239, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666013
10.
HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
Cardiovasc Diabetol;
21(1): 13, 2022 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35073913
11.
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes.
Cardiovasc Diabetol;
21(1): 266, 2022 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36461034
12.
Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis.
Diabetes Metab Res Rev;
38(1): e3476, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34018307
13.
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.
Diabetes Obes Metab;
24(9): 1734-1740, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546275
14.
Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins.
Nutr Metab Cardiovasc Dis;
32(9): 2255-2263, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961826
15.
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
BMC Med;
19(1): 66, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33715620
16.
Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register.
Cardiovasc Diabetol;
20(1): 173, 2021 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34446018
17.
Clinical profiles and quality of care of subjects with type 2 diabetes according to their cardiovascular risk: an observational, retrospective study.
Cardiovasc Diabetol;
20(1): 59, 2021 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676499
18.
Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study.
Cardiovasc Diabetol;
20(1): 28, 2021 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33516215
19.
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study.
Diabetes Obes Metab;
23(8): 1823-1833, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852202
20.
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts.
Diabetes Obes Metab;
23(7): 1484-1495, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606897